Skip to main content

Are you Dr. Castro?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 50 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    3300 Gallows Rd
    Falls Church, VA 22042
    Phone+1 703-776-3111
    Fax+1 904-346-0113

Summary

  • Dr. Elena Castro, MD is a board certified emergency medicine physician in Falls Church, Virginia. She is currently licensed to practice medicine in Virginia, District of Columbia, and Maryland.

Education & Training

  • University of Florida College of Medicine Jacksonville
    University of Florida College of Medicine JacksonvilleResidency, Emergency Medicine, 2003 - 2006
  • Georgetown University School of Medicine
    Georgetown University School of MedicineClass of 2003

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2015 - 2027
  • MD State Medical License
    MD State Medical License 2008 - 2026
  • VA State Medical License
    VA State Medical License 2006 - 2016
  • FL State Medical License
    FL State Medical License 2006 - 2012
  • Emergency Medicine
    American Board of Emergency Medicine Emergency Medicine

Publications & Presentations

PubMed

Press Mentions

  • Adding Talazoparib to Enzalutamide Extends Progression-Free Survival in Metastatic Castration-Resistant Prostate Cancer
    Adding Talazoparib to Enzalutamide Extends Progression-Free Survival in Metastatic Castration-Resistant Prostate CancerFebruary 20th, 2023
  • PARP-inhibitor Combination Prolongs Progression-Free Survival in Metastatic Prostate Cancer
    PARP-inhibitor Combination Prolongs Progression-Free Survival in Metastatic Prostate CancerFebruary 17th, 2023
  • Adding Enzalutamide to ADT Plus AAP Unnecessary in Metastatic HSPC
    Adding Enzalutamide to ADT Plus AAP Unnecessary in Metastatic HSPCSeptember 11th, 2022
  • Join now to see all